Composite
47%
Novelty
Feasibility
Impact
Mechanistic
65%
Druggability
55%
Safety
50%
Confidence
26%

Mechanistic description

This hypothesis proposes that targeted enhancement of VPS26A subunit expression and stability can rescue retromer complex dysfunction by improving the structural integrity and assembly efficiency of the VPS26/VPS29/VPS35 heterotrimer. Unlike approaches focusing on VPS35 restoration, this strategy targets the cargo recognition subunit VPS26A, which serves as the critical interface between the retromer core and cargo-selective sorting nexins. The mechanism involves VPS26A-mediated stabilization of the entire retromer complex through enhanced protein-protein interactions at the endosomal membrane. Specifically, increased VPS26A levels would promote more robust binding between the cargo recognition domain and sorting nexin dimers (SNX1/SNX2 or SNX5/SNX6), leading to improved retrograde transport from endosomes to the trans-Golgi network. This approach addresses the fundamental assembly defects observed in neurodegenerative diseases where retromer dysfunction contributes to pathological protein accumulation. The intervention would utilize VPS26A overexpression vectors or small molecule stabilizers that enhance VPS26A folding and membrane recruitment. Evidence would focus on measuring retromer complex stability through co-immunoprecipitation assays, tracking cargo trafficking efficiency using fluorescent protein reporters, and quantifying endosomal morphology changes via electron microscopy. Success metrics include increased retromer complex half-life, restored mannose-6-phosphate receptor recycling, and reduced endosomal enlargement phenotypes. This VPS26A-centric approach offers a complementary strategy to VPS35-focused therapies by targeting the rate-limiting step of retromer assembly and cargo recognition specificity.

Evidence for (5)

  • VPS35 mutations cause autosomal-dominant Parkinson's disease with synaptic dysfunction

  • Retromer protein levels are reduced in AD hippocampus and correlate with cognitive decline

  • Retromer dysfunction causes APP mislocalization to endosomes, increasing Aβ production

  • R55 compound rescues VPS35 mutations and restores retromer function in cellular models

  • Retromer mediates retrieval of synaptic receptors (APP, Vps10, SorLA) from degradative pathway

Evidence against (6)

  • VPS35 mutations cause Parkinson's, not Alzheimer's - mechanistic disconnect

  • VPS35 overexpression in mouse models causes dopamine neuron degeneration

  • Retromer enhancement increases Aβ production in some cellular models by redirecting APP to amyloidogenic compartments

  • R55 compound validation limited to HeLa cells and yeast; no human neuron data

  • Retromer affects thousands of cargo including Wntless, glutamate receptors, transferrin receptor

  • Correlation between VPS35 levels and cognitive decline may be secondary to neurodegeneration